Primary Site >> Biliary tract Cancer
Gene >> SLC17A5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Pyogenic liver abscess in Taiwan: emphasis on gas-forming liver abscess in diabetics. PMID: 8237941 |
Ref: Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicentre study. The Italian PSC Study Group. PMID: 8853259 |
Ref: Leucine amino peptidase a better indicator of carcinoma of liver, biliary tract and pancreas. PMID: 23105293 |
Ref: Activated partial thromboplastin time abnormality in patients with cholangiocarcinoma. PMID: 14979409 |
Ref: Up-regulation of PSF2, a member of the GINS multiprotein complex, in intrahepatic cholangiocarcinoma. PMID: 16077978 |
Ref: Outcome of surgical resection for hilar cholangiocarcinoma in elderly patients. PMID: 19260461 |
Ref: Biliary rhabdomyoscarcoma mimicking choledochal cyst. PMID: 19337643 |
Ref: Proteomics analysis and evaluation of biomarkers for detection of cholangiocarcinoma. PMID: 22126489 |
Ref: SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma. PMID: 21748296 Ref: Hepatic extraction fraction: interest of its quantification in patients with hepatic tumours. PMID: 22683967 |
Ref: Ability of biochemical parameters to distinguish between bile duct cancer and gall bladder stones--a case control study in a tertiary care hospital of Pokhara Valley. PMID: 23621244 Ref: Prognostic factors of distal cholangiocarcinoma after curative surgery: a series of 84 cases. PMID: 24719923 |
Ref: S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma. PMID: 24423918 Ref: Measurement of serum carcinoembryonic antigen, carbohydrate antigen 19-9, cytokeratin-19 fragment and matrix metalloproteinase-7 for detecting cholangiocarcinoma: a preliminary case-control study. PMID: 25368272 |
Ref: Nimesulide-induced fatal acute liver failure in an elderly woman with metastatic biliary adenocarcinoma. A case report. PMID: 25250798 Ref: Total serum bile acid as a potential marker for the diagnosis of cholangiocarcinoma without jaundice. PMID: 25743800 Ref: Exploring the diagnosis markers for gallbladder cancer based on clinical data. PMID: 26177708 |
Ref: Gallbladder small cell carcinoma: a case report and literature review. PMID: 27457076 |
Ref: Serum liver enzymes serve as prognostic factors in patients with intrahepatic cholangiocarcinoma. PMID: 28331337 Ref: A Phase 1 study of ARQ 087, an oral pan-FGFR inhibitor in patients with advanced solid tumours. PMID: 28972963 |
Ref: Treatment strategy for successful hepatic resection of icteric liver. PMID: 29593191 Ref: [Curative effect analysis of bile reinfusion combined with enteral nutrition support before surgery of hilar cholangiocarcinoma]. PMID: 29779313 Ref: Nutritional prognostic scores in patients with hilar cholangiocarcinoma treated by percutaneous transhepatic biliary stenting combined with 125I seed intracavitary irradiation: A retrospective observational study. PMID: 29851859 Ref: Inflammation-based prognostic scores in patients with extrahepatic bile duct lesions treated by percutaneous transhepatic biliary stenting combined with (125)I seeds intracavitary irradiation. PMID: 30368724 |